OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progress in immunotherapy
Bing Sun, Ningshao Xia, Xuan Zhang
Science China Life Sciences (2023) Vol. 66, Iss. 4, pp. 653-657
Open Access | Times Cited: 7
Bing Sun, Ningshao Xia, Xuan Zhang
Science China Life Sciences (2023) Vol. 66, Iss. 4, pp. 653-657
Open Access | Times Cited: 7
Showing 7 citing articles:
Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy
Xiaowen Zhou, Li Yang, Xiangrui Zhang, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 5, pp. 996-1009
Closed Access | Times Cited: 10
Xiaowen Zhou, Li Yang, Xiangrui Zhang, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 5, pp. 996-1009
Closed Access | Times Cited: 10
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 7
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 7
Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies
Jianlin Zhou, Xinjie Lu, Rui-Rui He, et al.
Science China Life Sciences (2025)
Closed Access
Jianlin Zhou, Xinjie Lu, Rui-Rui He, et al.
Science China Life Sciences (2025)
Closed Access
mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice
Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 14
Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 14
Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy
Shengzhe Jin, Hongfei Wang, Yang Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Shengzhe Jin, Hongfei Wang, Yang Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer
Wei Wen, Yuehua Li, Xi Cao, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 6, pp. e429-e451
Open Access | Times Cited: 3
Wei Wen, Yuehua Li, Xi Cao, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 6, pp. e429-e451
Open Access | Times Cited: 3
The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease
Yangju Fu, Yongbo Zheng
Frontiers in Oncology (2023) Vol. 13
Open Access
Yangju Fu, Yongbo Zheng
Frontiers in Oncology (2023) Vol. 13
Open Access
